Mastodawn

#FDA grants quick review for 3 #psychedelic #drugtrials
FDA Commissioner Marty Makary told NBC News that the first psychedelic #drug could be approved in the U.S. as soon as this summer
UK-based biotech company Compass Pathways for a synthetic #psilocybin for treatment-resistant #depression
Usona Institute received a voucher for its work with psilocybin to treat major depressive disorder
New York-based Transcend Therapeutics for its experimental drug #methylone for #PTSD
https://www.nbcnews.com/health/health-news/fda-psychedelic-drugs-psilocybin-methylone-review-depression-ptsd-rcna341677

FDA grants quick review for 3 psychedelic drug trials

The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder.

NBC News

Alan Kotok Sep 21, 2023

A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.

https://sciencebusiness.technewslit.com/?p=45241

#News #Press #Science #Business #Collaboration #Trama #Methylone #PTSD #Psychedelic #Psychoactive #Neurons #Prelinical #Veterans #DoD #Psychiatry #University #Therapy

Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy

A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.

Science and Enterprise

Alan Kotok Feb 23, 2023

Psychoactive Drug Start-Up Raises $40M in Early Funds

A new company is underway developing #drugs to treat #PTSD and other disorders with #psychoactive compounds claimed to be safer than current #psychedelics.

https://sciencebusiness.technewslit.com/?p=44483

#News #Science #Business #StartUp #Entrepreneurs #Neuroscience #MentalHealth #MDMA #Methylone #ClinicalTrial #Finance #VentureCapital

Psychoactive Drug Start-Up Raises $40M in Early Funds

A new company is underway developing drugs to treat PTSD and other disorders with psychoactive compounds claimed to be safer than current psychedelics.

Science and Enterprise